Seen that? - Biobarcode awarded patent for early cancer detection

Filed in archive Best of on February 26, 2010

Biobarcode awarded patent for early cancer detection Nanotechbuzz

Nanosphere Inc. announced today that it has been awarded a patent for its biobarcode technology. Biobarcode is a protein detection technology that is both more sensitive and less expensive than the mass spectrometry used today. It promises much earlier detection of diseases including cancer and Alzheimer' s. The technology was developed at Northwestern University and is esclusively licensed to Nanosphere. more @ nanotechwire.com [...] Read More


Rice University awarded $3 million for breast cancer research Nanotechbuzz

The Department of Defense has named Rice University the recipient of a $3 million award to develop miniaturized molecular imaging technologies for screening, diagnosis, and monitoring of breast cancer. The program calls for the development of microendoscope and needle-compatible fiber optic systems that doctors can use for a variety of diagnostic and therapeutic breast cancer imaging needs, ranging from early detection to guiding surgery to monitoring the efficacy of radiation [...] Read More


NCI Alliance for Nanotechnology in Cancer Nanotechbuzz

The government is serious about investing resources to research cures for cancer. This includes nanotechnology research aimed at improving patient outcomes. The phrase "nanotech oncology" is a buzzword these days because of the immense amount of research that is being conducted around the world. Will nanotechnology be the magical answer to cure cancer? Or will it be a combination of new drug delivery plus nanotechnology-driven drug delivery mechanisms? I often [...] Read More


CA1-18 Tumor Marker Assay for Early Detection and Diagnosis of Colorectal Cancer The Biotech Weblog

EDP Biotech Corporation has developed an immunodiagnostic test for colorectal cancer called CA1-18 Enzyme Immunoassay (EIA). The CA1-18 test is a monoclonal-polyclonal sandwich EIA for the quantitative measurement of CA1-18 (Tennessee Antigen) in human serum. Tennessee Antigen, a tumor-associated antigen, is present in elevated levels in the serum of patients with various carcinomas, particularly colorectal cancer. The diagnostic test is now available to research customers, and DP plans to submit the CA1-18 [...] Read More


What is Cancer Anyway? Here’s a Basic Definition We Can Fight Cancer Weblog

Carolin Zehetmeier, Morphosys AG, GermanyOriginally uploaded by GE HealthcareOur bodies are made up of cells. In a healthy body, these cells live out their happy lives doing all the things cells are supposed to do: They grow, divide, and at the end of their natural time, die, with a "next generation" of cells doing the same, replacing them. The cycle continues. Cancer begins when cells refuse to adhere to [...] Read More